European Surgical Research

Original Paper

Effect of the Portacaval Shunt on Reperfusion Injury after 65% Hepatectomy in Pigs

Farantos C.a · Arkadopoulos N.a · Theodoraki K.a · Kostopanagiotou G.d · Katis K.e · Tzavara K.f · Andreadou I.g · Dimopoulou K.b · Hatzoudi E.c · Sidiropoulou T.d · Skalkidis I.a · Paphiti A.b · Smyrniotis V.a

Author affiliations

aSecond Department of Surgery, and Departments of bPathology and cMicrobiology, Athens University School of Medicine, Aretaieion University Hospital, dSecond Department of Anesthesiology, Athens University School of Medicine, Attikon University Hospital, eDepartment of Surgery, 401 Military Hospital, fFirst Department of Internal Medicine, Red Cross Hospital, and gDepartment of Pharmaceutical Chemistry, Athens University School of Pharmacy, Athens, Greece

Related Articles for ""

Eur Surg Res 2008;40:347–353

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 22, 2007
Accepted: October 02, 2007
Published online: February 26, 2008
Issue release date: May 2008

Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 3

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR

Abstract

Background: Portal flow diversion by portacaval shunts (PCS) has been shown to prevent primary graft nonfunction in liver transplantation using small-for-size grafts. In this study, we examine whether PCS can improve reperfusion injury after major hepatectomy in pigs. Materials and Methods: In 14 pigs, a partial PCS was constructed following 65% hepatectomy and 1 h of inflow ischemia. During 24 h of reperfusion, the shunt was either closed (group A, n = 7) or left open (group B, n = 7). Results: 24 h after reperfusion, group A had higher levels of alanine aminotransferase (70 ± 12 IU/l vs. 51 ± 5.9 IU/l; p < 0.05), alanine aminotransferase per gram of liver remnant (0.41 ± 0.07 IU/l/g vs. 0.21 ± 0.05 IU/l/g; p < 0.05), prothrombin time (24.1 ± 2.4 s vs. 14.3 ± 2.9 s; p < 0.05), international normalized ratio (2.11 ± 0.15 vs. 1.29 ± 0.28; p < 0.05), hepatocyte necrosis scores and percentages of nuclei stained for proliferating cell nuclear antigen (52.57 ± 8.9% vs. 36.71 ± 6%; p < 0.05) compared to group B. Conclusions: Partial portal flow diversion appears to attenuate reperfusion injury in a porcine model of major hepatectomy.

© 2008 S. Karger AG, Basel




Related Articles:


References

  1. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, Jochum W: A prospective study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843–852.
  2. Smyrniotis V, Arkadopoulos N, Kostopanagiotou G, Theodoropoulos T, Theodoraki K, Farantos Ch, Kairi E, Paphiti A: Attenuation of ischemic injury by N-acetylcysteine preconditioning of the liver. J Surg Res 2005;129:31–37.
  3. Ku Y, Fukumoto T, Nishida T, Tominaga M, Maeda I, Kitagawa T, Takao S, Shiotani M, Tseng A, Kuroda Y, Saitoh Y: Evidence that portal vein decompression improves survival of canine quarter orthotopic liver transplantation. Transplantation 1995;59:1388–1392.
  4. Boillot O, Delafosse B, Mechet I, Boucaud C, Pouyet M: Small-for-size partial liver graft in an adult recipient: a new transplant technique. Lancet 2002;359:406–407.
  5. Troisi R, Ricciardi S, Smeets P, Petrovic M, Van Maele G, Colle I, Van Vlierberghe H, de Hemptinne B: Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant 2005;5:1397–1404.
  6. Man K, Lo CM, Nj IOL, Wong YC, Qin LF, Fan ST, Wong J: Liver transplantation in rats using small-for-size grafts. Arch Surg 2001;136:280–285.
  7. Smyrniotis V, Kostopanagiotou G, Kondi A, Gamaletsos E, Theodoraki K, Kehagias D, Mystakidou K, Contis J: Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int 2002;15:355–360.
  8. Man K, Fan ST, Lo CM, Liu CL, Fung PCW, Liang TB, Lee TKW, Tsui SHT, Nj IOL, Zhang ZW, Wong J: Graft injury in relation to graft size in right lobe liver donor liver transplantation. A study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003;237:256–264.
  9. Panis Y, McMullan DM, Emond JC: Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 1997;121:142–149.
  10. Fukuchi T, Hirose H, Onitsuka A, Hayashi M, Senga S, Imai N, Shibata M, Yamauchi K, Futamura N, Sumi Y: Effects of portal-systemic shunt following 90% partial hepatectomy in rats. J Surg Res 2000;89:126–131.
  11. Sankary HN, Yin DP, Chong AS, Ma LL, Blinder L, Shen JK, Foster P, Liu LP, Li C, Williams JW: The portosystemic shunt protects liver against ischemic reperfusion injury. Transplantation 1999;68:958–963.
  12. Andreadou I, Iliodromitis EK, Mikros E, Bofilis E, Zoga A, Constantinou M, Tsantili-Kakoulidou A, Kremastinos DT: Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med 2004;37:500–510.
  13. Assy N, Gong Y, Zhang M, Pettigrew NM, Pashniak D, Minuk GY: Use of proliferating cell nuclear antigen as a marker of liver regeneration after partial hepatectomy in rats. J Lab Clin Med 1998;131:251–256.
  14. Van Wagensveld BA, Van Gulik TM, Gelderblom HC, Scheepers JJG, Bosma A, Endert E, Gouma DJ: Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs. Ann Surg 1999;229:376–384.
  15. Nordlinger B, Douvin D, Javaudin L, Bloch P, Aranda A, Boschat M, Huguet C: An experimental study of survival after two hours of normothermic hepatic ischaemia. Surg Gynecol Obstet 1980;150:859–864.
  16. Marcos A, Olzinski AT, Ham JM, Fisher RA, Posner MP: The interrelationship between portal and arterial blood flow after adult living donor liver transplantation. Transplantation 2000;70:1697–1703.
  17. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K: Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999;67:321–327.
  18. Lo CM, Fan ST, Liu CL, Chan JK, Lam BK, Lau GK, Wei WI, Wong J: Minimum graft size for successful living donor liver transplantation. Transplantation 1999;68:1112–1116.
  19. Yagi S, Iida T, Taniguchi K, Hori T, Hamada T, Fujii K, Mizuno S, Uemoto S: Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl 2005;11:68–75.
  20. Takada Y, Ueda M, Ishikawa Y, Fujimoto Y, Miyauchi H, Ogura Y, Ochiai T, Tanaka K: End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 2004;10:807–810.
  21. Sato Y, Yamamoto S, Takeishi T, Kato T, Nakatsuka H, Kobayashi T, Oya H, Watanabe T, Kokai H, Hatakeyama K: Inferior mesenteric venous left renal vein shunting for decompression of excessive portal hypertension in adult living related liver transplantation. Transplant Proc 2004;36:2234–2236.
  22. Nishizaki T, Ikegami T, Hiroshige S, Hashimoto K, Uchiyama H, Yoshizumi T, Kishikawa K, Shimada M, Sugimachi K: Small graft for living donor liver transplantation. Ann Surg 2001;233:575–580.
  23. Galle PR: Apoptosis in liver disease. J Hepatol 1997;27:405–412.
  24. Suzuki S, Toledo-Pereyra LH: Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 1994;57:253–258.
  25. Brock RW, Lawlor DK, Harris KA, Potter RF: Initiation of remote hepatic injury in the rat: interactions between Kupffer cells, tumor necrosis factor-α, and microvascular perfusion. Hepatology 1999;30:137–142.
  26. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien P: Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997;26:1513–1520.
  27. Jaeschke H, Farhood A: Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991;260:6355–6362.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: February 22, 2007
Accepted: October 02, 2007
Published online: February 26, 2008
Issue release date: May 2008

Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 3

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP